The use of non-targeted metabolomics to assess the toxicity of bifenthrin to juvenile Chinook salmon (Oncorhynchus tshawytscha)

• Published in: Aquatic toxicology Vol. 224; p. 105518
• Main Authors: Magnuson, Jason T., Giroux, Marissa, Cryder, Zachary, Gan, Jay, Schlenk, Daniel
• Format: Journal Article
• Language: English
• Published: Elsevier B.V 01.07.2020
• Subjects: Apoptosis; Bifenthrin; Metabolomics; Nucleosides; Salmonids; Nucleosides; Metabolomics; Salmonids; Bifenthrin; Apoptosis
• ISSN: 0166-445X; 1879-1514
• DOI: 10.1016/j.aquatox.2020.105518

•Metabolomic profile altered in the brains of bifenthrin-exposed Chinook salmon.•Metabolites involved in apoptotic responses dysregulated in exposed salmon.•Metabolites involved in inflammatory responses dysregulated in exposed salmon.•Caspase 3 expression significantly increased in the brains of exposed Chinook. An increase in urban and agricultural application of pyrethroid insecticides in the San Francisco Bay Estuary and Sacramento San Joaquin Delta has raised concern for the populations of several salmonids, including Chinook salmon (Oncorhynchus tshawytscha). Bifenthrin, a type I pyrethroid, is among the most frequently detected pyrethroids in the Bay-Delta watershed, with surface water concentrations often exceeding chronic toxicity thresholds for several invertebrate and fish species. To better understand the mechanisms of bifenthrin-induced neurotoxicity, juvenile Chinook salmon were exposed to concentrations of bifenthrin previously measured in the Delta. Non-targeted metabolomic profiles were used to identify transcriptomic changes in the brains of bifenthrin-exposed fish. Pathway analysis software predicted increased apoptotic, inflammatory, and reactive oxygen species (ROS) responses in Chinook following exposure to 0.15 and 1.50 μg/L bifenthrin for 96 h. These responses were largely driven by reduced levels of inosine, hypoxanthine, and guanosine. Subsequently, in the brain, the expression of caspase 3, a predominant effector for apoptosis, was significantly upregulated following exposure to 1.50 μg/L bifenthrin. This data suggests that metabolites involved in inflammatory and apoptotic responses, as well as those involved in maintaining proper neuronal function may be disrupted following sublethal exposure to bifenthrin and further suggests that additional population studies should focus on behavioral responses associated with impaired brain function.